Lenvaxen 4 mg uses
Parameter Clinical Specification Active Pharmaceutical Ingredient (API) Lenvatinib Mesylate INN (equivalent to 4 mg Lenvatinib free base) Innovator Reference Drug Lenvima® (Eisai Co., Ltd. / Merck & Co.) Manufacturer Everest Pharmaceuticals Ltd. Pharmacological Class Multi-Targeted Receptor Tyrosine Kinase (RTK) Inhibitor / Anti-Angiogenic Primary Molecular Targets VEGFR1 (FLT1), VEGFR2 (KDR), VEGFR3 (FLT4), FGFR1–4, PDGFRα, KIT, RET […]